- Home
- HOUR vs XLO Comparison
HOUR vs XLO Comparison
Compare HOUR & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- XLO
- Stock Information
- Founded
- HOUR 2015
- XLO 2016
- Country
- HOUR United States
- XLO United States
- Employees
- HOUR N/A
- XLO N/A
- Industry
- HOUR Catalog/Specialty Distribution
- XLO Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- XLO Health Care
- Exchange
- HOUR Nasdaq
- XLO Nasdaq
- Market Cap
- HOUR 50.2M
- XLO 42.1M
- IPO Year
- HOUR 2022
- XLO 2021
- Fundamental
- Price
- HOUR $1.41
- XLO $0.90
- Analyst Decision
- HOUR
- XLO Buy
- Analyst Count
- HOUR 0
- XLO 1
- Target Price
- HOUR N/A
- XLO $4.00
- AVG Volume (30 Days)
- HOUR 19.7K
- XLO 126.1K
- Earning Date
- HOUR 11-12-2024
- XLO 11-07-2024
- Dividend Yield
- HOUR N/A
- XLO N/A
- EPS Growth
- HOUR N/A
- XLO N/A
- EPS
- HOUR 0.05
- XLO N/A
- Revenue
- HOUR $143,314,112.00
- XLO $4,620,000.00
- Revenue This Year
- HOUR $39.97
- XLO N/A
- Revenue Next Year
- HOUR N/A
- XLO $368.76
- P/E Ratio
- HOUR $30.07
- XLO N/A
- Revenue Growth
- HOUR 15.71
- XLO N/A
- 52 Week Low
- HOUR $0.83
- XLO $0.49
- 52 Week High
- HOUR $2.20
- XLO $1.93
- Technical
- Relative Strength Index (RSI)
- HOUR 45.09
- XLO 40.20
- Support Level
- HOUR $1.40
- XLO $0.83
- Resistance Level
- HOUR $1.74
- XLO $1.12
- Average True Range (ATR)
- HOUR 0.12
- XLO 0.09
- MACD
- HOUR -0.00
- XLO -0.02
- Stochastic Oscillator
- HOUR 19.51
- XLO 24.14
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).